Myogenica, Inc.

Private

Minneapolis, MinnesotaHealthcare & Life Scienceshttps://www.myogenica.com/

Last Round

Grant

Apr 1, 2024

Total Funding Raised

$600,000

Company Overview

Myogenica, Inc. is a biotechnology company that develops induced pluripotent stem cell-derived muscle stem cell therapies for the treatment of muscular dystrophy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyinduced pluripotent stem cellsiPSCmuscular dystrophyregenerative medicinemuscle stem cellsbiotechDuchenne muscular dystrophyDMDclinical-stage biotechmyogenic progenitorgene therapyoff-the-shelf therapydrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myogenica, Inc. Comps

Public and private peers based on sector, stage, and business model.

Myogenica, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myogenica, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2024
Seed	Mar 22, 2022

View all Funding Rounds

Myogenica, Inc. Investors

Notable investors and investment history

Myogenica, Inc. investors
Investor	Rounds
Parent Project Muscular Dystrophy	Grant
Duchenne UK	Grant
SeedFolio	Seed

View all Investors

Myogenica, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Myogenica, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myogenica, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota

Year Founded2022

Last FundingApr 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.